Kiora Pharmaceuticals, Inc. (KPRX)

NASDAQ

$2.36

$-0.05

(-2.10%)

Pre-Market

Kiora Pharmaceuticals, Inc. (KPRX) Live Price Chart

Last updated: ⁦2026-10-21 10:24:20⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Kiora Pharmaceuticals, Inc. (KPRX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.36, with a market capitalization of $10.53M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.76 to $2.91. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$10.53M
Open	$2.38
Day's High	$730.80
Day's Low	$1.76
Previous Close	$2.38
Volume	23.39K
Average Volume	16.12K
P/E Ratio	--
52-Week High	$2.91
52-Week Low	$1.76
Dividend Yield	--
Earnings Date	--

Kiora Pharmaceuticals, Inc. (KPRX) Pre-Market Stock Price

Kiora Pharmaceuticals, Inc. (KPRX) is trading at $2.48 in pre-market trading as of 2026-10-20 19:59:45, up 4.12% ($0.10) from the previous close of $2.38

Pre-market trading shows how investors are pricing KPRX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Kiora Pharmaceuticals, Inc. (KPRX) 7-Day Stock Price Change

Over the past seven days, Kiora Pharmaceuticals, Inc. (KPRX) moved from $2.56 to $2.36, representing a decline of 7.70% ($0.20).

The stock traded between $2.32 and $2.56 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 14.03 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

KPRX 52-Week Price Position

Position in Range: 52.2%

52W Low$1.76

52W High$2.91

KPRX is currently trading at $2.36, placing it 52.2% of the way from its 52-week low of $1.76 to its 52-week high of $2.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Kiora Pharmaceuticals, Inc. (KPRX)?

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

Kiora Pharmaceuticals, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	13
Exchange	NASDAQ
Company Website	https://www.kiorapharma.com

How to Buy Kiora Pharmaceuticals, Inc. (KPRX) Stock on MEXC

Eligible investors can buy real shares of Kiora Pharmaceuticals, Inc. (KPRX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for KPRX and Place Your Order

Open the RealStocks trading page and search for KPRX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Kiora Pharmaceuticals, Inc. (KPRX) stock price today?

Kiora Pharmaceuticals, Inc. (KPRX) is currently trading at $ 2.36, down 0.71% ($0.02) from the previous close of $ 2.38. Intraday prices update in real time during regular trading hours.

2.Is KPRX stock going up or down today?

As of 2026-10-20 19:59:45, KPRX is trading at $ 2.36, down 0.71% ($0.02) from its previous close of $ 2.38. The stock has traded between $ 1.76 and $ 730.80 during today’s regular session. Past price movements do not guarantee future results.

3.What is KPRX pre-market price?

As of 2026-10-20 19:59:45, KPRX is trading at $ 2.48 in pre-market trading, up 4.12% ($0.10) from the previous close of $ 2.38. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is KPRX after-hours price?

As of 2026-10-20 19:59:45, KPRX is trading at $ 2.37 in after-hours trading, down 0.63% ($0.01) from the regular-session close of $ 2.38. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is KPRX stock trading now?

KPRX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does KPRX sit relative to its 52-week high and low?

Over the past 52 weeks, KPRX has traded between a low of $ 1.76 and a high of $ 2.91. At $ 2.36, the stock is positioned 52.2% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Kiora Pharmaceuticals, Inc. in?

Kiora Pharmaceuticals, Inc. (KPRX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Kiora Pharmaceuticals, Inc.'s market capitalization and where is it listed?

Kiora Pharmaceuticals, Inc. is listed on the NASDAQ exchange with a market capitalization of $ 10.53M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is KPRX valued in terms of P/E ratio and EPS?

KPRX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -2.48. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Kiora Pharmaceuticals, Inc. pay a dividend?

Kiora Pharmaceuticals, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.